Malignant Nasopharyngeal Neoplasm — Trials

Malignant Nasopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 261
Recruiting: 139
Ph III recruiting: 56
Growth YoY: +5.2%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 24.1%
Trials / 1,000 deaths: 376.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 151–200 of 244 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03723343	GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma	unknown	—	146	Guiyang Medical UniversityOTHER	1	Oct 29, 2018	clinicaltrials
NCT03701451	Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma	unknown	Phase 1 / Phase 2	30	Wei JiangOTHER	1	Oct 10, 2018	clinicaltrials